| Net Cash Provided by (Used in) Operating Activities |
$78,227 |
USD |
|
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$158,068 |
USD |
-127% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$301,789 |
USD |
-974% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
7,714,701 |
shares |
21% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,392,105 |
USD |
119% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$5,970,000 |
USD |
30% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$5,970,000 |
USD |
30% |
Q2 2025 |
FY 2025 |
| Operating Lease, Liability |
$82,341 |
USD |
-44% |
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$24,349 |
USD |
-21% |
Q3 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$5,211,695 |
USD |
13% |
Q3 2025 |
Q1 2026 |
| Operating Lease, Liability, Current |
$50,995 |
USD |
-71% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$4,854,000 |
USD |
21% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$69,453,956 |
USD |
11% |
Q3 2025 |
Q1 2026 |
| Depreciation, Depletion and Amortization |
$65,181 |
USD |
35% |
Q3 2025 |
Q1 2026 |
| Share-based Payment Arrangement, Expense |
$1,764,381 |
USD |
76% |
Q3 2025 |
Q1 2026 |
| Interest Expense |
$41,775 |
USD |
-35% |
Q3 2025 |
Q1 2026 |